FdaApplication
NDA 020951
Identifiers
- fda_app_no: NDA020951
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE |
| application_type | NDA |
| approval_date | 1999-07-09 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TAGAMET HB 200 | CIMETIDINE | 200MG/20ML | SUSPENSION;ORAL |
1 product